The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more...
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
Before shots begin, the Centers for Disease Control and Prevention must recommend how they should be used, a decision expected next week. Sharon Bentley of Argyle, Texas, is one of the holdouts. Bentley was hesitant about the first COVID-19 vaccines but then her husband volunteered for a Novavax trial, getting two doses and later a booster.
Like the other vaccines used in the U.S., the Novavax shots have proved highly effective at preventing COVID-19's most severe outcomes. Typical vaccine reactions were mild, including arm pain and fatigue. But FDA did warn about the possibility of a rare risk, heart inflammation, that also has been seen with the Pfizer and Moderna vaccines.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
US regulators OK new COVID-19 shot option from NovavaxThe U.S. is getting another COVID-19 vaccine choice
Baca lebih lajut »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
Baca lebih lajut »
Masks urged in New York City as COVID-19 omicron subvariant BA.5 cases tick upAs COVID-19 cases tick up in New York City, the Department of Health is continuing to urge residents to wear masks in all public indoor settings and in crowded areas outdoors.
Baca lebih lajut »
COVID-19 symptoms can linger for many weeks, CDC study saysThe symptoms could be a headache, a runny nose, a sore throat, as well as loss of smell, taste or hair. Some could even struggle with fatigue, chills or fever.
Baca lebih lajut »
Omicron subvariants threaten COVID-19 resurgence across USHealth officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S.
Baca lebih lajut »